Please assess the completion status of the following clinical trial:

Trial Title: Assessing the Efficacy of Virtual Reality Analgesia (VRA) in Pediatric Patients for Pain Control

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Children with spasticity requiring BTI~* Children ages 5 - 18~* Children who have contraindications for sedation for BTI~* Children with intact vision who can attend VR intervention~Exclusion Criteria:~* Children who have uncontrolled seizures \> than 4 per year~* Children who are not attentive to VR secondary to poor concentration, poor cognition to external stimuli~* Children on different treatments for spasticity such as baclofen pump, phenol block. For patients who receive phenol block, phenol block will be held during the visits with VR intervention to avoid confounding results~* Children with poor bleeding control~* Children who request general anesthesia/IV sedation.

- Gender: ALL
- Minimum Age: 5 Years
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- Google Cardboard VRA (Type: ACTIVE_COMPARATOR): This group of subjects will receive VRA intervention using Google Cardboard Virtual reality head- mounted display powered by a iPod touch.
- Oculus Rift VRA (Type: ACTIVE_COMPARATOR): This group of subjects will receive VRA with Oculus Rift
- Control (Type: NO_INTERVENTION): This group of subjects will receive no intervention beyond standard sedation, anesthetic, and/or restraint-this group will serve as the control group

Based on this trial design, predict the completion outcome and termination type (if applicable).